These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 35015881)
1. New life for an old therapy: ELTD1 as a downstream target of angiogenesis. Tiek DM; Cheng SY Neuro Oncol; 2022 Mar; 24(3):412-413. PubMed ID: 35015881 [No Abstract] [Full Text] [Related]
2. A review of ELTD1, a pro-angiogenic adhesion GPCR. Favara DM; Banham AH; Harris AL Biochem Soc Trans; 2014 Dec; 42(6):1658-64. PubMed ID: 25399586 [TBL] [Abstract][Full Text] [Related]
3. ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models. Ziegler J; Pody R; Coutinho de Souza P; Evans B; Saunders D; Smith N; Mallory S; Njoku C; Dong Y; Chen H; Dong J; Lerner M; Mian O; Tummala S; Battiste J; Fung KM; Wren JD; Towner RA Neuro Oncol; 2017 Feb; 19(2):175-185. PubMed ID: 27416955 [TBL] [Abstract][Full Text] [Related]
4. A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis. Masiero M; Simões FC; Han HD; Snell C; Peterkin T; Bridges E; Mangala LS; Wu SY; Pradeep S; Li D; Han C; Dalton H; Lopez-Berestein G; Tuynman JB; Mortensen N; Li JL; Patient R; Sood AK; Banham AH; Harris AL; Buffa FM Cancer Cell; 2013 Aug; 24(2):229-41. PubMed ID: 23871637 [TBL] [Abstract][Full Text] [Related]
5. ELTD1-An Emerging Silent Actor in Cancer Drama Play. Sevastre AS; Buzatu IM; Baloi C; Oprita A; Dragoi A; Tataranu LG; Alexandru O; Tudorache S; Dricu A Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068040 [TBL] [Abstract][Full Text] [Related]
6. Generation of an ELTD1 knockout human embryonic stem cell line by the iCRISPR/Cas9 system. Luo Q; Wei C; Long Y; Zhang M; Shan W; Li H; Cai S; Xu Y; Qian P; Huang H Stem Cell Res; 2021 May; 53():102350. PubMed ID: 34087984 [TBL] [Abstract][Full Text] [Related]
7. Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib. Niinivirta M; Georganaki M; Enblad G; Lindskog C; Dimberg A; Ullenhag GJ BMC Cancer; 2020 Apr; 20(1):339. PubMed ID: 32321460 [TBL] [Abstract][Full Text] [Related]
8. ELTD1 promotes invasion and metastasis by activating MMP2 in colorectal cancer. Sun J; Zhang Z; Chen J; Xue M; Pan X Int J Biol Sci; 2021; 17(12):3048-3058. PubMed ID: 34421349 [TBL] [Abstract][Full Text] [Related]
9. A tale of two multi-focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone-based OKN-007. Zalles M; Smith N; Saunders D; Lerner M; Fung KM; Battiste J; Towner RA J Cell Mol Med; 2022 Jan; 26(2):570-582. PubMed ID: 34910361 [TBL] [Abstract][Full Text] [Related]
10. ELTD1 deletion reduces vascular abnormality and improves T-cell recruitment after PD-1 blockade in glioma. Huang H; Georganaki M; Conze LL; Laviña B; van Hooren L; Vemuri K; van de Walle T; Ramachandran M; Zhang L; Pontén F; Bergqvist M; Smits A; Betsholtz C; Dejana E; Magnusson PU; He L; Lugano R; Dimberg A Neuro Oncol; 2022 Mar; 24(3):398-411. PubMed ID: 34347079 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker. Serban F; Artene SA; Georgescu AM; Purcaru SO; Tache DE; Alexandru O; Dricu A Onco Targets Ther; 2015; 8():3767-74. PubMed ID: 26719704 [TBL] [Abstract][Full Text] [Related]
12. ELTD1 facilitates glioma proliferation, migration and invasion by activating JAK/STAT3/HIF-1α signaling axis. Li J; Shen J; Wang Z; Xu H; Wang Q; Chai S; Fu P; Huang T; Anas O; Zhao H; Li J; Xiong N Sci Rep; 2019 Sep; 9(1):13904. PubMed ID: 31554859 [TBL] [Abstract][Full Text] [Related]
13. Apelin/APJ system: A novel promising therapy target for pathological angiogenesis. Wu L; Chen L; Li L Clin Chim Acta; 2017 Mar; 466():78-84. PubMed ID: 28025030 [TBL] [Abstract][Full Text] [Related]
14. Augmented cardiac hypertrophy in response to pressure overload in mice lacking ELTD1. Xiao J; Jiang H; Zhang R; Fan G; Zhang Y; Jiang D; Li H PLoS One; 2012; 7(5):e35779. PubMed ID: 22606234 [TBL] [Abstract][Full Text] [Related]
15. G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts. De Francesco EM; Sotgia F; Clarke RB; Lisanti MP; Maggiolini M Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29240722 [TBL] [Abstract][Full Text] [Related]